几丁质酶-3样蛋白1等生物标志物用于创伤性脑损伤颅内严重度评估
这项前瞻性观察队列纳入115例格拉斯哥 coma 评分3-15分的创伤性脑损伤患者,分析多种血清生物标志物与颅内出血病灶体积及位置的关系。结果显示SAA1、YKL-40、PCT和S100β与意识水平关联最强,且与多种颅内出血体积显著相关;YKL-40、SAA1、CRP和PCT联合S100β是判断颅内病灶存在、位置和范围最有前景的标志物组合。
要点
- SAA1、YKL-40、PCT和S100β与GCS总分及运动评分关联最稳健。
- 生物标志物与硬膜下血肿、创伤性蛛网膜下腔出血、脑实质出血、脑室内出血及总出血量显著相关。
- YKL-40、SAA1、CRP和PCT联合S100β最有前景,联合检测可提高颅内出血判别能力。
核心结论
- YKL-40、SAA1、CRP和PCT联合S100β是判断创伤性颅内病灶存在、位置和范围最有前景的生物标志物组合。
- 联合多种生物标志物可进一步提高检测颅内出血的判别能力。
研究设计与样本
- 前瞻性观察队列研究,纳入115例GCS评分3-15分的创伤性脑损伤患者。
- 通过CT血肿半自动分割测量颅内病灶体积,采用Youden指数基于ROC曲线下面积估计生物标志物 cutoff 点。
主要发现
- SAA1、YKL-40、PCT和S100β与意识水平(GCS总分和运动评分)关联最稳健。
- 生物标志物与硬膜下血肿、创伤性蛛网膜下腔出血、脑实质出血、脑室内出血及总出血量的体积测量显著相关。
- 颅内出血类型与神经生化标志物的不同释放模式相关。
临床怎么用
- 可考虑联合检测YKL-40、SAA1、CRP、PCT和S100β辅助判断创伤性颅内病灶的存在、位置和范围。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The volume and location of intracranial hematomas are well-known prognostic factors for traumatic brain injury. The aim of this study was to determine the relationship of serum biomarkers S100β, glial fibrillary acidic protein, neuron-specific enolase, total tau, phosphorylated neurofilament heavy chain, serum amyloid A1 (SAA1), C-reactive protein, procalcitonin (PCT), and chitinase-3-like protein 1 (YKL-40) with traumatic brain injury severity and the amount and location of hemorrhagic traumatic lesions. METHODS: A prospective observational cohort of 115 patients with a Glasgow Coma Scale (GCS) score of 3-15 were evaluated. Intracranial lesion volume was measured from the semiautomatic segmentation of hematoma on computed tomography using Analyze software. The establishment of possible biomarker cutoff points for intracranial lesion detection was estimated using the Youden Index (J) obtained from the area under the receiver operating characteristic curve. RESULTS: SAA1, YKL-40, PCT, and S100β showed the most robust association with level of consciousness, both with total GCS and motor score. Biomarkers significantly correlated with volumetric measurements of subdural hematoma, traumatic subarachnoid hemorrhage, intraparenchymal hemorrhage, intraventricular hemorrhage, and total amount of bleeding. The type of intracranial hemorrhage was associated with various release patterns of neurobiochemical markers. CONCLUSIONS: YKL-40, SAA1, C-reactive protein, and PCT combined with S100β were the most promising biomarkers to determine the presence, location, and extent of traumatic intracranial lesions. Combination of biomarkers further increased the discriminatory capacity for the detection of intracranial bleeding.
引用
- Carabias CS, Gomez PA, Panero I, et al. Chitinase-3-Like Protein 1, Serum Amyloid A1, C-Reactive Protein, and Procalcitonin Are Promising Biomarkers for Intracranial Severity Assessment of Traumatic Brain Injury: Relationship with Glasgow Coma Scale and Computed Tomography Volumetry. World Neurosurg. 2019. PMID: 31606503. doi:10.1016/j.wneu.2019.09.143
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。